FundPlus
Investor profile
Venture capital
Also recorded as: Fund plus
Deals
12
distinct rounds
Companies
9
backed
Active span
2021–2025
5 yrs
Total round €
€742M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Andera Partners4
- Hadean Ventures3
- INKEF Capital3
- Bayern Kapital2
- BioMedPartners2
- Coparion2
- CR-CP Life Science Fund2
- Curie Capital2
- First Venture2
- High-Tech Gründerfonds (HTGF)2
- InvestSud2
- Kurma Partners2
- LSP2
- New Science Ventures2
- OCCIDENT2
- Omnes Capital2
- Seroba Life Sciences2
- Seventure Partners2
- SRIW Life Sciences2
- Sunstone Life Science Ventures2
- Utrecht Health Seed Fund2
- V-Bio Ventures2
- VIVES Louvain Technology Fund2
- Ackermans & van Haaren1
- Ascenta Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Novadip Biosciences | Belgium | 2 | €59M |
| Coave Therapeutics | France | 2 | €53M |
| Minoryx Therapeutics | Spain | 1 | €51M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| eTheRNA | Belgium | 1 | €39M |
| AstriVax | Belgium | 1 | €30M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| Novadip Biosciences | Series B | €40M | 2022-11 |
| eTheRNA | Series B | €39M | 2022-08 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| AstriVax | Seed | €30M | 2022-08 |